Abstract
The mammalian neprilysin (NEP) family comprises at least seven members: NEP itself, Kell blood group antigen (KELL), the endothelin-converting enzymes (ECE-1 and ECE-2), the enzyme PEX, associated with X-linked hypophosphataemia,“X-converting enzyme” (XCE) a CNS-expressed orphan peptidase and a soluble, secreted endopeptidase (SEP). These zinc metallopeptidases are all type II integral membrane proteins. Where identified, these enzymeshave roles in the processing or metabolism of regulatory peptides and therefore represent potential therapeutic targets. A distinct feature of ECE-1 species is their existence as distinct isoforms differing in their N-terminal cytoplasmic tails. These tails play a role in enzyme targeting and turnover with di-leucine and tyrosine-based motifs affecting localization. Additional anchorage of these enzymes can also occur through palmitoylation. Bacterial homologues of the neprilysin family exist, for example the products of the pepO genes from L. lactis and S. parasanguis, and a recently described gene product of P. gingivalis which is an ECE-1 homologue that can catalyse the conversion of big endothelin to endothelin. A genomicsbased approach to understanding the functions of thisproteinase family is aided by the completion of the C. elegans and Drosophila genomes, both of which encode multiple copies of NEP-like enzymes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ahn, K., Herman, S.B.,and Fahnoe, D.C., 1998, Soluble human endothelin-converting enzyme-1: Expression, purification, and demonstration of pronounced pH sensitivity. Arch. Biochem. Biophys. 359: 258–268.
Awano, S., Ansai, T., Mochizuki, K, Tanzawa, K., Turner, A. J., and Takehara, T., 1999, Sequencing, expression and biochemical characterization of the Porphyromonas gingivalis pepO gene encoding a protein homologous to human endothelin converting enzyme. FEBS Lett. in press.
Azarani, A., Boileau, G., and Crine, P., 1998, Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells. Biochem. J. 333: 439–448.
Barnes, K., and Turner, A. J., 1997 The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies. Neurochem. Res. 22: 1033–1040.
Barnes, K., and Turner, A. J., 1999, Endothelinconverting enzyme is located onα-actin filaments in smooth muscle cells. Cardiovasc. Res. 42: 814–822.
Barnes, K., Turner, A. J., and Kenny, A. J., 1993, An immunoelectron microscopic study of pig substantia-nigra shows colocalization of endopeptidase-24. 11 with substance P. Neuroscience 53: 1073–1082.
Barnes, K., Shimada, K., Takahashi, M, Tanzawa, K., and Turner, A. J., 1996, Metallopeptidase inhibitorsinduce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J Cell Sci. 109: 919–928.
Barnes, K., Brown, C., and Turner, A. J., 1998, Endothelin-converting enzyme. Ultrastructural localization and its recycling from the cell surface. Hypertension 31: 3–9.
Barrett, A. J., Rawlings, N. D., and Woessner, J. F. (eds.), 1998, Handbook of Proteolytic Enzymes, Academic Press, London and San Diego, pp. 1033–1037.
Baynash, A. G., Hosoda, K., Giaid, A., Richardson, J. A., Emoto, N., Hammer, R. E., and Yanagisawa, M., 1994, Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 1277–1285.
Brown, C., Barnes, K., and Turner, A. J., 1998, Anti-peptideantibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression. FEBS Lett. 424: 183–187.
Cailler, F., Zappulla, J. P., Boileau, G., and Crine, P., 1999, The N-terminal segment of endothelin-converting enzyme (ECE)-lb contains a di-leucinemotif that can redirect neprilysin to an inracellular compartment in Madin-Darby canine kidney (MDCK) cells. Biochem. J. 341: 119–126.
Devault, A., Lazure, C., Nault, C., Le Moual, H., Seidah, N. G., Chrétien, M., Kahn, P., Powell, J., Mallet, J., Beaumont, A., Roques, B. P., Crine, P., and Boileau, G., 1987, Ammoacid sequence ofrabbit kidneyneutralendopeptidase-24.11 (enkephalinase) deduced from a complementary DNA. EMBO J. 6: 1317–1322.
Emoto, N., and Yanagisawa, M, 1995, Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloproteasewith acidic pH optimum. J. Biol. Chem. 270: 15262–15268.
Emoto, N., Nurhantari, Y., Alimsardjono, H., Xie, J., Yamada, T., Yanagisawa, M., and Matsuo, M., 1999, Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-la mediated by novel signals in its alternatively spliced cytoplasmic tail. J. Biol Chem. 274: 1509–1518.
Froeliger, E. H., Oetjen, J., Bond, J. P., and Fives-Taylor, P., 1999, Streptococcus parasanguis pepO encodes an endopeptidase with structure and activity similar to those of enzymes that modulate peptide receptor signaling in eukaryotic cells. Infect. Immunity 67: 5206–5214.
Hoang, M. V., and Turner, A. J., 1997, Novel activity for endothelin-converting enzyme: hydrolysis of bradykinin. Biochem. J. 327: 23–26.
Hoang, M. V., Sansom, C. E., and Turner, A. J., 1997, Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin converting enzyme. Biochem. J. 327: 925–929.
Hofstra, R. M. W., Valdenaire, O., Arch, E., Osinga, J., Kroes, H., Löffler, B-M., Hamosh, A., Meijers, C., and Buys, C. H. C. M., 1999, A loss-of-function mutation in the endothelin-converting enzyme-1(ECE-1) associated with Hirschsprung Disease, cardiac defects, and autonomic dysfunction. Am. J. Hum. Genet. 64: 304–308.
HYP Consortium, 1995, A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet. 11: 130–136.
Ikeda, K., Emoto, N., Raharjo, S. B., Nurhantari, Y., Saiki, K., Yokoyama, M., and Matsuo, M., 1999, Molecular identification and characterization of novel membrane-bound metalloprotease, the solublesecreted form of whichhydrolyzesavarietyof vasoactive peptides. J. Biol. Chem. 274: 32469–32477.
Johnson, G. D., Stevenson, T., and Ahn, K., 1999, Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin. J. Biol. Chem. 274: 4053–4058.
Kenny, A. J., and Stephenson, S.L., 1988, Role of endopeptidase-24.11in the inactivation of atrial natriuretic peptide. FEBS Lett. 232: 1–8.
Lee, S., Lin, M., Mele, A., Cao, Y., Farmar, J., Russo, D., and Redman, C., 1999, Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 94: 1440–1450.
Lipman, M. L., Panda, D., Bennett, H. P. J., Henderson, I. E., Shane, E., Shen, Y., Goltzman, D., and Karaplis, A. C., 1998, Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity. J. Biol. Chem. 273: 13729–13737.
Malfroy, B., Swerts, J. P., Guyon, A., and Roques, B. P., 1978, High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 276: 523–526.
Malfroy, B., Schofield, P. R., Kuang, W. J., Seeburg, P. H., Mason, A. J., and Henzel, W. J., 1987, Molecular cloning and amino acid sequence of rat enkephalinase. Biochem. Biophys. Res. Commun. 144: 59–66.
Matsas, R., Fulcher, I. S., Kenny, A. J. and Turner, A. J., 1983, Substance P., and [Leu]enkephalin are hydrolysed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. Natl. Acad. Sei. USA 80: 3111–3115.
Papandreou, C. N., Usmani, B. A., Geng, Y., Bogenreider, T., Freeman, R., Wilk, S., Finstad, C. I,, Reuter, V.E., Powell, C. T., Scheinberg, D., Magill, C., Scher, H. I., Albino, A. P., and Nanus, D.M., 1998, Neutral endopeptidase 24.11 loss in metstatic human prostate cancer contributes to androgen-independent progression. Nature Med. 4: 50–57.
Roques, B. P., Fournié-Zaluski, M-C., Soroca, E., Lecomte, J-M., Malfroy, B., Llorens-Cortes, C., and Schwartz, J.-C., 1980, The enkephalinase inhibitorthiorphan shows antinociceptive activity in mice. Nature 288: 286–288.
Roques, B.P., Noble, F., Daugé, V., Foumié-Zaluski, M-C., and Beaumont, A., 1993, Neutral endopeptidase 24.11. Structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45: 87–146.
Ruchon, A.F., Marcinkiewicz, M., Siegfried, G., Tenehouse, H.S., DesGroseillers, L., Crine, P., and Boileau, G., 1998, Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J. Histochem. Cytochem. 46: 459–468.
Russo, D., Redman, C., and Lee, S., 1998, Association of XK and Kell blood group proteins. J. Biol. Chem. 273: 13950–13956.
Sansom, C.E., Hoang, M.V., and Turner, A.J., 1998, Molecular modelling and sire-directed mutagenesis of the active site of endothelin converting enzyme. Protein Eng. 11: 1235–1241.
Schweizer, A., Valdenaire, O., Nelbock, P., Deuschle, U., Edwards, J.B.D.M., Stumpf, J.G., and Löffler, B.M., 1997, Human endothelin-converting enzyme (ECE-1): three isofonns with distinct subcellular locations. Biochem. J. 328: 871–877.
Schweizer, A., Löffler, B-M, and Rohrer, J., 1999a, Palmitoylation of the three isoforms of human endothelin-converting enzyme-1. Biochem. J. 340: 649–656.
Schweizer, A., Valdenaire, O., Köster, A., Lang, Y., Schmitt, G., Lenz, B., Bluethmann, H., and Rohrer, J., 1999b, Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family. J. Biol. Chem. 274: 20450–20456.
Shimada, K., Takahashi, M., Turner, A.J., and Tanzawa, K., 1996, Rat endothelin-converting enzyme-1 fprms a dimer through Cys(412) with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem. J. 315: 863–867.
Shipp, MA. Stefano, G.B., Switzer, S.N., Griffin, S.N., and Reinherz, E.L., 1991, CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration and adhesion proteins and is itself regulated by neutrophil activation. Blood 78: 1834–1841.
Tiraboschi, G., Jullian, N., Thery, V., Antonczak, S., Foumie-Zaluski, M-C., and Roques, M.P., 1999, A three-dimensional construction of the active site (region 507–749) of human neutral endopeptidase (EC3.4.24.11). Protein Eng. 12: 141–149.
Turner, A.J., 1998, Neprilysin. In: Handbook of Proteolytic Enzymes. (A.J. Barrett, N.D. Rawlings and J.F. Woessner, eds), Academic Press, London and San Diego, pp. 1080–1083.
Tuner, A.J., 1998, Neprilysin. In: Handbook of Proteolytic Enzymes. (A.J. Barrett, N.D. Rawlings and J.F. Woessner, eds), Academic Press, London and San Diego, pp. 1080–1083.
Turner, A.J., and Murphy, L.J., 1996, Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51: 91–102.
Turner, A.J., and Tanzawa, K., 1997, Mammalian membrane metallopeptidases: NEP, ECE, KELL and PEX. FASEB J. 11: 355–364.
Turner, A.J., Barnes, K., Schweizer, A., and Valdenaire, O., 1998, Isoforms of endothelin-converting enzyme: why and where? Trends Pharmacol. Sci. 19: 483–486.
Valdenaire, O., Rohrbacher, E., and Mattei, M.G., 1995, Organisation of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem. 270: 29794–29798.
Valdenaire, O., Lepailleur-Enouf, D., Egidy, G., Thouard, A., Barret, A., Vranckx, R., Tougard, C., and Michel, J.-B., 1999a, A fourth isoform of endothelin-converting enzyme-1 is generated from an additional promoter. Molecular cloning and characterization. Eur. J. Biochem. 264: 1–10.
Valdenaire, O., Barret, A., Schweizer, A., Rohrbacher, E., Mongiat, F., Pinet, F., Corvol, P., and Tougard, C., 1999b, Two di-leucine-based motifs account for the different subcellular localizations of the human endothelin-converting enzyme (ECE-1) isoforms. J. Cell Sci. 112: 3115–3125.
Valdenaire, O., Richards, J. G., Faull, R. L.M., and Schweizer, A., 1999c, XCE, a new member of the endothelin-converting enzyme and neutral endopeptidase family, is preferentially expressed in the CNS. Mol. Brain Res. 64: 211–221.
Yanagisawa, H., Yanagisawa, M., Kapur, R. P., Richardson, J.A., Williams, S.C., Clouthier, D. E., deWit, D., Emoto, N., and Hammer, R. E., 1998, Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125: 825–836.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Turner, A.J., Brown, C.D., Carson, J.A., Barnes, K. (2002). The Neprilysin Family in Health and Disease. In: Langner, J., Ansorge, S. (eds) Cellular Peptidases in Immune Functions and Diseases 2. Advances in Experimental Medicine and Biology, vol 477. Springer, Boston, MA. https://doi.org/10.1007/0-306-46826-3_25
Download citation
DOI: https://doi.org/10.1007/0-306-46826-3_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46383-9
Online ISBN: 978-0-306-46826-1
eBook Packages: Springer Book Archive